In Vivo Insulin Sensitivity and Secretion in Obese Youth What are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?

被引:84
作者
Bacha, Fida [1 ,2 ]
Gungor, Neslihan [3 ]
Lee, SoJung [2 ]
Arslanian, Silva A. [1 ,2 ]
机构
[1] Childrens Hosp Pittsburgh, Div Pediat Endocrinol Metab & Diabet Mellitus, Pittsburgh, PA 15213 USA
[2] Childrens Hosp Pittsburgh, Weight Management & Wellness Ctr, Pittsburgh, PA 15213 USA
[3] Anadolu Saglik Merkezi Gebze, Kocaeli, Turkey
关键词
BETA-CELL FUNCTION; NATURAL-HISTORY; RISK-FACTORS; RESISTANCE; CHILDREN; INDIVIDUALS; DYSFUNCTION; ADOLESCENTS; PREVALENCE; PREDICTORS;
D O I
10.2337/dc08-1030
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
OBJECTIVE - Impaired glucose tolerance (IGT) represents a pre-diabetic state. Controversy continues in regards to its pathophysiology. The aim of this study was to investigate the differences in insulin sensitivity (IS) and secretion in obese adolescents with IGT compared with those with normal glucose tolerance (NGT) and type 2 diabetes. RESEARCH DESIGN AND METHODS - A total of 12 obese adolescents with NGT, 19 with IGT, and 17 with type 2 diabetes undement CV evaluation of insulin sensitivity (3-h hyperinsulinemic [80mu/m(2)/min]-euglycemic clamp), first-phase insulin and second-phase insulin secretion (2-h hyperglycemic clamp), body composition, and abdominal adiposity. Glucose disposition index (GDI) was calculated as the product of first-phase insulin X insulin sensitivity. RESULTS - Insulin-stimulated glucose disposal was significantly lower in subjects with type 2 diabetes compared with subjects with NGT and IGT, with no difference between the latter two. However, compared with youth with NGT, youth with IGT have significantly lower first-phase insulin and C-peptide levels and GDI (P = 0.012), whereas youth with type 2 diabetes have an additional defect in second-phase insulin Fasting and 2-h glucose correlated with GD1 (r=-0.68, P < 0.001 and r=-0.73 P < 0.001, respectively) and first-phase insulin but not with insulin sensitivity. CONCLUSIONS - Compared with youth with NGT. obese adolescents with IGT have evidence of a beta-cell defect manifested in impaired first-phase insulin secretion, with a more profound defect in type 2 diabetes involving both first- and second-phase insulin. GDI shows a significantly declining pattern: it is highest in NGT, intermediate in IGT, and lowest in type 2 diabetes. Such data suggest that measures to prevent progression or conversion from pre-diabetes to type 2 diabetes should target improvement in beta-cell function.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 25 条
[1]
Glucose intolerance in obese adolescents with polycystic ovary syndrome:: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease [J].
Arslanian, SA ;
Lewy, VD ;
Danadian, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :66-71
[2]
Adiponectin in youth -: relationship to visceral adiposity, insulin sensitivity, and β-cell function [J].
Bacha, F ;
Saad, R ;
Gungor, N ;
Arslanian, SA .
DIABETES CARE, 2004, 27 (02) :547-552
[3]
Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents [J].
Bacha, Fida ;
Saad, Rola ;
Gungor, Neslihan ;
Arslanian, Silva A. .
DIABETES CARE, 2006, 29 (07) :1599-1604
[4]
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents [J].
Cali, Anna M. G. ;
Bonadonna, Riccardo C. ;
Trombetta, Maddalena ;
Weiss, Ram ;
Caprio, Sonia .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05) :1767-1773
[5]
Predictors of progression from impaired glucose tolerance to NIDDM - An analysis of six prospective studies [J].
Edelstein, SL ;
Knowler, WC ;
Bain, RP ;
Andres, R ;
BarrettConnor, EL ;
Dowse, GK ;
Haffner, SM ;
Pettitt, DJ ;
Sorkin, JD ;
Muller, DC ;
Collins, VR ;
Hamman, RF .
DIABETES, 1997, 46 (04) :701-710
[6]
β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes:: A new analysis [J].
Ferrannini, E ;
Gastaldelli, A ;
Miyazaki, Y ;
Matsuda, M ;
Mari, A ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :493-500
[7]
The natural course of β-cell function in nondiabetic and diabetic individuals -: The insulin resistance atherosclerosis study [J].
Festa, A ;
Williams, K ;
D'Agostino, R ;
Wagenknecht, LE ;
Haffner, SM .
DIABETES, 2006, 55 (04) :1114-1120
[8]
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose [J].
Festa, A ;
D'Agostino, R ;
Hanley, AJG ;
Karter, AJ ;
Saad, MF ;
Haffner, SM .
DIABETES, 2004, 53 (06) :1549-1555
[9]
Genuth S, 2003, DIABETES CARE, V26, P3160
[10]
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis [J].
Gillies, Clare L. ;
Abrams, Keith R. ;
Lambert, Paul C. ;
Cooper, Nicola J. ;
Sutton, Alex J. ;
Hsu, Ron T. ;
Khunti, Kamlesh .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7588) :299-302B